Reversible Inactivation of Purified Leukocyte Integrin CR3 (CD11b/CD18, β_mβ₂) by Removal of Divalent Cations from a Cryptic Site

References

• Bajt M. L., Goodman T., McGuire S. L. β2 (CD18) mutations abolish ligand recognition by I domain integrins LFA-1 (αLβ2, CD11a/CD18) and Mac-1 (αMβ2, CD11b/CD18). J. Biol. Chem. 1995; 270: 94–98
   PubMed Web of Science ®Google Scholar
• Bebbington C. R., Hentschel C. C.G. The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells. DNA Cloning: A Practical Approach, D. M. Glover. IRL Press, OxfordUK 1987; Vol. III: 163–188
   Google Scholar
• Brown T. A. Molecular Biology: Labfax. Academic Press, LondonUK 1991; 42
   Google Scholar
• Cai T. Q., Wright S. D. Energetics of leukocyte integrin. J. Biol. Chem. 1995; 270: 14358–14365
   PubMed Web of Science ®Google Scholar
• Cockett M. I., Bebbington C. R., Yananton G. T. High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine systhetase gene amplification. Bio/Technology 1990; 8: 662–667
   PubMed Web of Science ®Google Scholar
• Corbi A. L., Kishimoto T. K., Miller L. J., Springer T. A. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) a subunit: cloning, primary structure, and relation to the integrins, von willebrand factor and factor B. J. Biol. Chem. 1988; 263: 12403–12411
   PubMed Web of Science ®Google Scholar
• Dana N., Styrt B., Griffin J. D., Todd I R. F., II, Klempner M. S., Arnaout M. A. Two functional domains in the phagocyte membrane glycoprotein Mo 1 identified with monoclonal antibodies. J. Immunol. 1986; 137: 3259–3263
   PubMed Web of Science ®Google Scholar
• Diamond M. S., Staunton D. E., Fougerolles A. R.D., Stacker S. A., Garcia-Aguilar J., Hibbs M. L., Springer T. A. ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 1990; 111: 3129–3139
   PubMed Web of Science ®Google Scholar
• Diamond M. S., Springer T. A. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 1993; 120: 545–556
   PubMed Web of Science ®Google Scholar
• Diamond M. S., Garcia-Aguilar J., Bickford J. K., Corbi A. L., Springer T. A. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 1993; 120: 1031–1043
   PubMed Web of Science ®Google Scholar
• Du X., Plow E. F., Frelinger A. L., Otoole T. E., Loftus J. C., Ginsberg M. H. Ligands “activate” integrin αIIbβ3 (platelet Gp11b-111a). Cell. 1991; 65: 409–416
   PubMed Web of Science ®Google Scholar
• Hermanowski-Vosatka A., Van Strijp J. A.G., Swiggard W. J., Wright S. D. Integrin modulating factor-1: A lipid that alters the function of leukocyte integrins. Cell. 1992; 68: 341–352
   PubMed Web of Science ®Google Scholar
• Lee J. O., Rieu P., Amaout M. A., Liddington R. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11b/CD18). Cell. 1995; 80: 631–638
   PubMed Web of Science ®Google Scholar
• Lo S. K., Detmers P. A., Levin S. M., Wright S. D. Transient adhesion of neutrophils to endothelium. J. Exp. Med. 1989; 169: 1779–1793
   PubMed Web of Science ®Google Scholar
• Michishita M., Videm V., Arnput M. A. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell. 1993; 72: 857–867
   PubMed Web of Science ®Google Scholar
• Ortlepp S., Stephen P. E., Hogg N., Figdor C. G., Robinson M. K. Antibodies that activate β2 integrins can generate different ligand binding states. Eur. J. Immunol. 1995; 25: 637–643
   PubMed Web of Science ®Google Scholar
• Robinson M. K., Andrew D., Rosen H., Brown D., Ortlepp S., Stephens P., Butcher E. C. Antibody against the leu-CAM β- chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. J. Immun. 1992; 148: 1080–1085
   PubMed Web of Science ®Google Scholar
• Smyth S. S., Hillery C. A., Parise L. V. Fibrinogen binding to purified platelet glycoprotein 11b-111a (integrin α11bβ3) is modulated by lipids. J. Biol. Chem. 1992; 267: 15568–15577
   PubMed Web of Science ®Google Scholar
• Smyth S. S., Parise L. V. Regulation of ligand binding to glycoprotein 11b-111a (integrin α11bβ3) in isolated platelet membranes. Biochem. J. 1993; 292: 749–758
   PubMed Web of Science ®Google Scholar
• Uciechowski P., Schmidt R. Cluster report CD11. Leukocyte Typing IV: White Cell Differentiation Antigens, W. Knapp, D. Dorken, W. Gilks, E. Rieber, R. Schmidt, H. Stein, A. von dem Borne. Oxford University Press, Oxford 1989; 543–551
   Google Scholar
• Ueda T., Rieu P., Brayer J., Amaout M. A. Identification of the complement iC3b binding site in the β2 integrin CR3 (CD11b/CD18). Proc. Natl. Acad. Sci. USA 1994; 91: 10680–10684
   PubMed Web of Science ®Google Scholar
• Van Voorhis W. C., Steinman R. M., Hair L. S., Luban J., Witmer M. D., Koide S., Cohn Z. A. Specific antimononu-clear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages. J. Exp. Med. 1983; 158: 125–145
   Web of Science ®Google Scholar
• Wright S. D., Rao P. E., Van Voorhis W. C., Craigmyle L. S., Iida K., Talle M. A., Westberg E. F., Goldstein G., Silverstein S. C. Identification of the C3bi receptor on human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1983; 80: 5699–5703
   PubMed Web of Science ®Google Scholar
• Wright S. D., Meyer B. C. Phorbol esters cause sequential activation and deactivation of complement receptors on polymophonuclear leukocytes. J. Immunol. 1986; 136: 1759–1764
   PubMed Web of Science ®Google Scholar
• Wright S. D., Weitz J. I., Huang A. D., Levin S. M., Silverstein S. C., Loike J. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc. Natl. Acad. Sci. USA 1988; 85: 7734–7738
   PubMed Web of Science ®Google Scholar
• Zhou L., Lee D. H.S., Plescia J., Lau C. Y., Alteri D. C. Differential ligand binding specificities of recombinant CD11/CD18 integrin I-domain. J. Biol. Chem. 1994; 269: 17075–17079
   PubMed Web of Science ®Google Scholar